ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $523,854 | +236.0% | 146,328 | +246.3% | 0.00% | – |
Q2 2023 | $155,902 | +37.0% | 42,250 | +44.0% | 0.00% | – |
Q4 2022 | $113,816 | -65.4% | 29,334 | -83.7% | 0.00% | -100.0% |
Q1 2022 | $329,000 | +600.0% | 179,996 | +435.1% | 0.00% | – |
Q4 2021 | $47,000 | -54.8% | 33,635 | -63.4% | 0.00% | – |
Q3 2021 | $104,000 | -77.9% | 91,926 | -68.7% | 0.00% | -100.0% |
Q2 2021 | $470,000 | -53.6% | 293,859 | -48.9% | 0.00% | -66.7% |
Q1 2021 | $1,013,000 | +325.6% | 575,325 | +370.4% | 0.01% | +200.0% |
Q4 2020 | $238,000 | +466.7% | 122,301 | +590.7% | 0.00% | +100.0% |
Q3 2020 | $42,000 | -82.0% | 17,706 | -77.7% | 0.00% | -75.0% |
Q2 2020 | $233,000 | +323.6% | 79,444 | +318.5% | 0.00% | +300.0% |
Q1 2020 | $55,000 | -57.7% | 18,982 | -41.7% | 0.00% | 0.0% |
Q4 2019 | $130,000 | +80.6% | 32,559 | +180.7% | 0.00% | 0.0% |
Q3 2018 | $72,000 | +44.0% | 11,600 | +5.0% | 0.00% | 0.0% |
Q2 2018 | $50,000 | – | 11,046 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |